XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share Based Payments Award Stock Options Valuation Assumptions

The fair value of stock-based awards was estimated using the Black-Scholes model with the following weighted average assumptions for the nine months ended September 30, 2023, and 2022:

 

   2023   2022 
Dividend yield   0.00%   0.00%
Risk-free interest rate   4.05%   0.95 -3.23%
Expected volatility   100.23-100.25%   106.40 -109.97%
Expected life (in years)   5    5 
Schedule of Warranty Activity

Warrant activity for the nine months ended September 30, 2023 and the year ended December 31, 2022 was as follows:

 

   Warrants   Weighted
Average
Exercise
Price ($)
   Weighted
Average
Remaining
Contractual
Life (Yrs.)
 
Warrants outstanding at December 31, 2021   199,397    122.00    2.10 
Granted   -    -    - 
Exercised   -    -    - 
Forfeited or cancelled   (8,233)   -    - 
Warrants outstanding at December 31, 2022   191,164    93.24    1.19 
Granted   151,483    6.42    2.19 
Exercised   -    -    - 
Forfeited or cancelled   (120,604)   90.72    - 
Warrants outstanding at September 30, 2023   222,043    26.48    2.07 
Stock Appreciation Rights [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Share Based Payments Award Stock Options Valuation Assumptions

The fair value of SAR awards was estimated using the Black-Scholes model with the following weighted average assumptions for the nine months ended September 30, 2023 and the year ended December 31, 2022:

 

   2023   2022 
Dividend yield   -    0.00%
Risk-free interest rate   -    0.82-2.79%
Expected volatility   -    108.0-119.0%
Expected life (in years)   -    5 
Schedule of Stock Option Activity

SARs activity for the nine months ended September 30, 2023 and the year ended December 31, 2022 was as follows:

 

   SARs   Weighted
Average
Exercise
Price ($)
   Weighted
Average
Remaining
Contractual
Life (Yrs.)
   Aggregate
Intrinsic
Value ($)
 
                 
SARs outstanding at December 31, 2021   18,532    63.00    4.24    - 
Granted   40,743    36.20    4.48    - 
Exercised   -    -    -        - 
Forfeited or cancelled   (1,386)   58.20    -    - 
SARs outstanding at December 31, 2022   57,889    44.20    4.11    - 
Granted   -    -    -    - 
Exercised   -    -    -    - 
Forfeited or cancelled   (17,432)   43.03-    -    - 
SARs outstanding September 30, 2023   40,457    44.75    3.40    - 
SARs unvested at September 30, 2023   17,051    54.92    3.04    - 
SARs vested at September 30, 2023   23,406    37.35    3.66    - 
SARs outstanding at September 30, 2023   40,457    44.75    3.40    -